20/20 Biolabs Wins Vermont Firefighter Cancer Screening Pact; Shares Dip

20/20 Biolabs secured a statewide contract to provide cancer screening for Vermont firefighters, but the company’s shares fell on May 27, 2026, as investors appeared unimpressed by the deal’s scope. The pact, covering all fire departments across the state, aims to offer early detection testing for cancers linked to occupational exposure. Financial terms were not disclosed. Despite the public-health significance of the agreement, the stock decline suggests market expectations for a larger commercial breakthrough or near-term revenue impact remain muted. The Vermont contract adds to 20/20 Biolabs’ portfolio of screening programs, yet the company has not provided updated guidance on how such state-level deals will translate to earnings growth. The move comes amid broader efforts by U.S. states to bolster health programs for first responders, but the financial payoff for test providers remains uncertain.